These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12978867)

  • 1. [Lymph node manifestations during treatments with 3-methyl-5, 5-phenylethylhydantoin].
    OLMER J; PAILLAS J; ROGER J; MURATORE R; BADIER
    Bull Mem Soc Med Hop Paris; 1952 Jun 20-27; 68(22-23):839-41. PubMed ID: 12978867
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymph node manifestations during methyl-phenyl-ethyl-hydantoin therapy].
    OLMER J; PAILLAS J; ROGER J; MURATORE R; BADIER M
    Presse Med (1893); 1952 Dec; 60(82):1748-50. PubMed ID: 13027182
    [No Abstract]   [Full Text] [Related]  

  • 3. [3-Methyl-5, 5-phenylethylhydantoin therapy of epilepsy].
    DONATI A; BERNARDI L
    Rass Studi Psichiatr; 1952; 41(6):1171-92. PubMed ID: 13047632
    [No Abstract]   [Full Text] [Related]  

  • 4. [The value of 3-methyl 5.5. phenylethylhydantoin in therapy of epilepsy].
    HOLTZER PA
    Geneeskd Gids; 1952 May; 30(9):181-7. PubMed ID: 14955069
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of adults for epilepsy; toxic effect of 3-methyl 5-5-phenylethylhydantoin.
    BAILEY AA; WORDEN RE
    Proc Staff Meet Mayo Clin; 1949 Sep; 24(19):483-6. PubMed ID: 18138747
    [No Abstract]   [Full Text] [Related]  

  • 6. MESANTOIN LYMPHADENOPATHY MORPHOLOGICALLY SIMULATING HODGKIN'S DISEASE.
    DOYLE AP; HELLSTROM HR
    Ann Intern Med; 1963 Sep; 59():363-8. PubMed ID: 14065954
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lymphadenopathy following triantoin in audiogenic epilepsy].
    POKORNA M; ROSSLER M
    Cesk Pediatr; 1962 Apr; 17():354-8. PubMed ID: 14487454
    [No Abstract]   [Full Text] [Related]  

  • 8. A NEW ANTICONVULSANT, 1-METHYL-5:5-PHENYLETHYLHYDANTOIN. ITS USE IN PEDIATRICS.
    OETTINGER L; NEKONISHI H
    Dev Med Child Neurol; 1965 Apr; 7():189-95. PubMed ID: 14317536
    [No Abstract]   [Full Text] [Related]  

  • 9. Generalized lymphadenopathy and hepatosplenomegaly induced by diphenylhydantoin.
    BAJOGHLI M
    Pediatrics; 1961 Dec; 28():943-5. PubMed ID: 13864097
    [No Abstract]   [Full Text] [Related]  

  • 10. [DISEASES OF THE CERVICAL LYMPH NODES. ANATOMY, DIFFERENTIAL DIAGNOSIS AND THERAPY].
    BECKER W
    Dtsch Med Wochenschr; 1964 Apr; 89():773-8. PubMed ID: 14160342
    [No Abstract]   [Full Text] [Related]  

  • 11. [Iatrogenic lymph node lesions (author's transl)].
    Leder LD; Lennert K
    Verh Dtsch Ges Pathol; 1972; 56():310-20. PubMed ID: 4130833
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphadenopathy resulting from long-term use of hydantoin.
    Szegedi G; Krasznai G; Sorszegi P; Szabó G
    Acta Med Acad Sci Hung; 1970; 27(3):243-51. PubMed ID: 5511166
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydantoin lymphadenopathy.
    Krasznai G; Györy G
    J Pathol Bacteriol; 1968 Jan; 95(1):314-7. PubMed ID: 5643463
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphadenopathy induced by ethotoin (peganone); clinical and pathological mimicking of malignant lymphoma.
    SALTZSTEIN SL; JAUDON JC; LUSE SA; ACKERMAN LV
    J Am Med Assoc; 1958 Jul; 167(13):1618-20. PubMed ID: 13563153
    [No Abstract]   [Full Text] [Related]  

  • 15. Syndrome simulatingqymphosarcoma induced by diphenylhydantoin sodium.
    ROSENFELD S; SWILLER AI; SHENOY YM; MORRISON AN
    JAMA; 1961 May; 176():491-3. PubMed ID: 13743450
    [No Abstract]   [Full Text] [Related]  

  • 16. [TUMOR-LIKE DRUG-INDUCED LYMPHADENOPATHY].
    DEVENYI I
    Zentralbl Allg Pathol; 1964 Apr; 105():535-7. PubMed ID: 14194808
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of 3-methyl-5, 5-phenyl-ethyl-hydantoin in therapy of epilepsy].
    HOLTZER PA
    Belg Tijdschr Geneesk; 1952 Sep; 8(18):817-31. PubMed ID: 13008950
    [No Abstract]   [Full Text] [Related]  

  • 18. [The injurious effect of hydantoins on bone marrow with reference to a fatal panmyelophthisis following sacerno (3-methyl 5, 5-phenylethylhydantoin) therapy].
    BAN A; BERCZELLER I
    Orv Hetil; 1952 Apr; 93(16):480-4. PubMed ID: 13003265
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental production of lymph node swellings by feeding of mesantoin].
    KASLARIS E
    Wien Klin Wochenschr; 1953 Dec; 65(50):1007-8. PubMed ID: 13147158
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphangiographic findings of mesantoin-induced pseudolymphoma.
    Sayoc AS; Howland WJ
    Radiology; 1974 Jun; 111(3):579-80. PubMed ID: 4828990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.